Abstract

BackgroundRegistration can help with transparency of acupuncture clinical trials (ACTs) by making protocol information and results available to the public. Recently, the number of registered ACTs has increased greatly, but only a few researchers have focused on the quality of ACTs registration. This review provides the first assessment of the registration quality of ACTs and the baseline information for future development.MethodsAll records of ACTs registered in the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) were collected. Data was extracted and input to Excel spreadsheets. The current 20 items of the WHO Trial Registration Data Set (TRDS) and the special prepared items for acupuncture intervention details were used to assess the registration quality of ACTs.ResultsA total of 740 records, found in 11 registries, were examined. The number of registered ACTs increased rapidly and involved a number of different diseases. The completeness of 20 items was not too poor due to 16 of them had a higher reported percentage (>85%). The completeness of the 20 items was different among registries. For example, the average registration percentage of 20 items in Clinicaltrials.gov, ChiCTR, ISRCTN and ANZCTR were 89.6%, 92.2%, 82.4% and 91.6% respectively. Detailed information regarding acupuncture intervention was seriously insufficient. Among the 740 registration records, 89.2% lacked information on the style of acupuncture, 80.8% did not contain details regarding the needles used, 53.5% lacked information on the treatment regimen and 76.2% did not give details of other interventions administered with acupuncture.ConclusionsThe overall registration quality of ACTs is not high enough due to the serious lack of information on the specifics of acupuncture intervention. It is vital that a number of special items be set regarding acupuncture in order to develop a suitable system for the registration of ACTs.

Highlights

  • As an alternative medicine methodology, acupuncture has proved effective for the treatment of many diseases and symptoms of disease, such as chronic pain, drug addiction, stroke rehabilitation, asthma and chemotherapy-induced nausea and vomiting [1,2]

  • The objective of this study is to summarize and evaluate the quality of acupuncture clinical trials (ACTs) registration with the current 20 items of the World Health Organization (WHO) trial registration data set (TRDS) [16] and the special prepared items for acupuncture intervention details, which will provide the baseline information for the future development of ACTs registration

  • A total of 914 registration records were retrieved in the registries

Read more

Summary

Introduction

As an alternative medicine methodology, acupuncture has proved effective for the treatment of many diseases and symptoms of disease, such as chronic pain, drug addiction, stroke rehabilitation, asthma and chemotherapy-induced nausea and vomiting [1,2]. Due to the availability of increased research funding, acupuncture clinical trials (ACTs) have been extensively conducted in many countries in recent decades. Problems with publication bias had extended to ACTs. Vickers reported that all ACTs from mainland China, Hong Kong, Taiwan and Japan were reported to be effective [10]. The high proportion of positive results reported in these countries was unusual, which could be attributed to publication and selective reporting bias [11]. Registration can help with transparency of acupuncture clinical trials (ACTs) by making protocol information and results available to the public. The number of registered ACTs has increased greatly, but only a few researchers have focused on the quality of ACTs registration. This review provides the first assessment of the registration quality of ACTs and the baseline information for future development

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.